Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Communication Regarding Thyroid Medication
In recognition of January being Thyroid Awareness Month, the FDA today issued an educational Q&A statement regarding thyroid medications. For more information, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm107377.htm
Learn More

FDA Communication Regarding New Anemia Drug Studies
The FDA today issued another statement regarding the safety of { drug_name } in the treatment of chemotherapy related anemia. It is currently reviewing new data from two studies that support previous statements made about tumor growth and death. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109375.htm
Learn More

Date Published Title Drug Source
2008-01-03 FDA Communication Regarding Thyroid Medication Thyroid FDA
2008-01-03 FDA Communication Regarding New Anemia Drug Studies FDA
2008-01-03 FDA Communication Regarding New Anemia Drug Studies Darbepoetin Alfa FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Alendronate FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Alendronate and Vitamin D FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Tiludronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Etidronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Ibandronate Sodium FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Risedronic Acid FDA
2008-01-07 FDA Communication Regarding Musculoskeletal Pain Actonel Plus Calcium FDA
2008-01-17 FDA recommendation regarding use in children Pseudoephedrine FDA
2008-01-18 Product label updated with new information about VTE risk Ortho Evra FDA
2008-01-27 Early communication regarding ongoing FDA review Ezetimibe with Simvastatin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Carbamazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Felbamate FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Gabapentin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Lamotrigine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Levetiracetam FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Oxcarbazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Pregabalin FDA